AI tool to improve colorectal cancer diagnosis and prognosis in Kenya
Leveraging artificial intelligence/machine learning-based technology to overcome specialized training and technology barriers for the diagnosis and prognostication of colorectal cancer in Africa
An artificial-intelligence computer program will read routine pathology slides to help diagnose and predict outcomes for people with colorectal cancer in Kenya.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aga Khan University (Kenya) NIH-funded |
| Lab location | 1 site (Nairobi, Kenya) |
| Project ID | NIH-11172236 on NIH RePORTER |
What this research studies
If I take part, my routine tissue slides from a colon biopsy or surgery will be digitally scanned and analyzed by an AI pipeline (SIVQ/VIPR) that identifies tumor features at the pixel level. The team will link those image features to clinical records to see how well the AI can match diagnoses and predict outcomes. This work is being done with partners at Aga Khan University East Africa, Tenwek Hospital in rural Bomet, and the University of Michigan using samples from an existing Kenyan patient group. The goal is to create an affordable, locally relevant tool that can work where trained pathologists and resources are scarce.
Who could benefit from this research
Good fit: Ideal candidates are people in the Kenyan cohort who have had colorectal biopsies or surgical specimens with available H&E slides and linked clinical outcome data.
Not a fit: People without available tissue slides, without linked clinical data, or whose care is outside the participating hospitals are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, this could speed up and improve diagnosis and prognosis information for colorectal cancer patients in areas with few pathologists, helping doctors choose better treatments sooner.
How similar studies have performed: Other AI-based pathology tools have shown promising accuracy, and the SIVQ/VIPR pipeline has previously outperformed subject-matter experts, but large-scale validation in an African clinical population is new.
Where this research is happening
Nairobi, Kenya
- Aga Khan University (Kenya) — Nairobi, Kenya (Active)
Researchers
- Principal investigator: Saleh, Mansoor N — Aga Khan University (Kenya)
- Study coordinator: Saleh, Mansoor N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.